| Bioactivity | 5-Azidomethyl-2’-beta-methyl uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-Azidomethyl-2’-beta-methyl uridine |
| CAS | 2305415-72-7 |
| Formula | C11H15N5O6 |
| Molar Mass | 313.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cavanagh BL, et al. Thymidine analogues for tracking DNA synthesis. Molecules. 2011 Sep 15;16(9):7980-93. [2]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
5-Azidomethyl-2’-beta-methyl uridine
CAS: 2305415-72-7 F: C11H15N5O6 W: 313.27
5-Azidomethyl-2’-beta-methyl uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor acti
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.